Table 2_Therapeutic impact of Mongolian Andai therapy on gut microbiota and metabolomic pr

A dataset from a 2026 study analyzing the effects of an 8-week Mongolian Andai therapy intervention on 20 patients with depression. It includes results from 16S rRNA sequencing of gut microbiota and blood metabolomic analysis, with bioinformatic analyses like PCA and KEGG enrichment. The data is provided by author Qila Sa under a CC-BY-4.0 license.

Use Cases

• Analyze changes in gut microbial phyla, such as Proteobacteria and Bacteroidota, based on therapy response.
• Investigate alterations in metabolic pathways like pyrimidine and purine metabolism mentioned in the results.
• Explore microbial-metabolite associations linked to therapeutic efficacy through integrated analysis.
• Validate findings from the study's bioinformatic methods, including PCA and KEGG enrichment.

Strengths

• Includes data from 20 patients undergoing a defined 8-week therapeutic intervention.
• Combines two analysis types: 16S rRNA sequencing for gut microbiota and metabolomics for blood metabolites.
• Dataset is openly available under a CC-BY-4.0 license, facilitating reuse.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is small in scale at 719.0 KB, indicating limited scope.

Provenance

Source

figshare

Collection Method

Clinical study involving 16S rRNA sequencing and metabolomic analysis of patient samples.

Time Range

Covers an 8-week therapy period.

Freshness

Last updated 2026-06-03 04:51:10; freshness should be verified.